Similar articles

• Prevention of myocardial reinfarction. Recommendations based on results of drug trials.

  Flaker GC, Singh VN. Flaker GC, et al. Postgrad Med. 1993 Nov 1;94(6):94-8, 102-4. Postgrad Med. 1993. PMID: 7901845 Review.
• Adjunctive therapy for myocardial infarction.

  Avezum A Jr, Flather MD, Yusuf S. Avezum A Jr, et al. Arq Bras Cardiol. 1995 Jul;65(1):97-110. Arq Bras Cardiol. 1995. PMID: 8546606 Review. No abstract available.
• Treatment of myocardial infarction in elderly patients.

  Sokolyk S, Tresch D. Sokolyk S, et al. Compr Ther. 1994;20(10):537-44. Compr Ther. 1994. PMID: 7859435 Review. No abstract available.
• Gender, ethnicity, and genes in cardiovascular disease. Part 2: implications for pharmacotherapy.

  Schaefer BM, Caracciolo V, Frishman WH, Charney P. Schaefer BM, et al. Heart Dis. 2003 May-Jun;5(3):202-14. doi: 10.1097/01.HDX.0000074437.07268.00. Heart Dis. 2003. PMID: 12783634 Review.
• The management of patients who have suffered an acute myocardial infarction in a tertiary care centre.

  Haddad H, Searles G, Gillis A. Haddad H, et al. Can J Cardiol. 2001 Feb;17(2):179-83. Can J Cardiol. 2001. PMID: 11223488